Randomized study of minocycline and edetic acid as a locking solution for central line (Port-A-Cath) in children with cancer

Chemotherapy

Volumn 57, Issue 4, 2011, Pages 285-291

  Ferreira Chacon, Julieta Maria ^a   Hato De Almeida, Emília ^a   De Lourdes Simões, Regina ^a   Lazzarin C Ozório, Viviane ^a   Alves, Benaia Cândida ^a   Mello De Andréa, Maria Lydia ^a   Santiago Biernat, Marcela ^b   Biernat, João Carlos ^b,c  

^a Hospital Estadual Infantil Darcy Vargas   (Brazil)

^b Clinirim   (Brazil)

^c NONE   (Brazil)

Author keywords

Biofilm; Central venous catheter; Chemotherapy; Contamination; Edetic acid; Heparin; Minocycline

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CATH SAFE; CEPHALOSPORIN; CHLORAMPHENICOL; EDETIC ACID; GLYCOPEPTIDE; HEPARIN; MACROLIDE; MINOCYCLINE; MONOBACTAM; NITROIMIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; BIOFILM; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANDIDA; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEATH; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; IMPLANTABLE PORT SYSTEM; INCIDENCE; INFECTION RATE; INFECTION RISK; KAPLAN MEIER METHOD; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SEPSIS; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79960524183     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000328976     Document Type: Article

References (46)

1. Capdevila JA, Gavalda J, Fortea J, López P, Martin MT, Gomis X, Pahissa A: Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001; 7: 206-212. (Pubitemid 34966119)
2. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, OToole GA: Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73: 4596-4606. (Pubitemid 41105614)
3. Chatzinikolaou I, Zipf TF, Hanna H, Umphrey J, Roberts WM, Sherertz R, Hachem R, Raad I: Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36: 116-119. (Pubitemid 36099107)
4. Banin E, Brady KM, Greenberg P: Chelatorinduced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 2006; 72: 2064-2069.
5. Donlan R, Arduino M, Carr J, Murga R, Eastwood K, Kite P, Percival SL: Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005; 26: 515-519. (Pubitemid 40896140)
6. Kite P, Eastwood K, Sugden S, Percival SL: Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004; 42: 3073-3076. (Pubitemid 38938060)
7. Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ: Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25: 149-151. (Pubitemid 27293088)
8. Hachem R, Chaiban G, Dvorak T, Hanna H, Raad I: Optimal antimicrobial catheter lock solution, using different combinations of Minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 2007; 51: 78-83. (Pubitemid 46047690)
9. Venkatesh M, Rong L, Raad I, Versalovic J: Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol 2009; 58: 936-944.
10. Sherertz R, Raad I, Hachem R, Tcholakian RK: Efficacy of Minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46: 327-332. (Pubitemid 34087176)
11. Raad I, Hachem R, Hanna H, Fang X, Jiang Y, Dvorak T, Sherertz R, Kontoyiannis D: Role of ethylene diamine tetra-acetic acid (EDTA) in a catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 2008; 32: 515-518.
12. Hachem R, Sherertz R, Jiang Y, Keutgen X, Fang X, Raad I: The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008; 21: 385-392.
13. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R: Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol 2005; 16: 648-654. (Pubitemid 40613333)
14. Abbas AA, Fryer CJ, Paltiel C, Chedid F, Felimban SK, Yousef AA, Khattab TM: Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004; 42: 325-331. (Pubitemid 38327625)
15. Beutel K, Simon A, Bode U: Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Inf 2006; 12: 606-620. (Pubitemid 43842480)
16. Dittmer ID, Sharp D, McNulty CA, Williams AJ, Banks RA: A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51: 34-39. (Pubitemid 29027404)
17. Simon A, Fleischhack G, Hasan C, Bode U, Engelhart S, Kramer MH: Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592-596.
18. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP: Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 1998; 32: 1627-1631.
19. Gil ML, Casanova M, Martínez JP: Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch Microbiol 1994; 161: 489-494. (Pubitemid 24192015)
20. Ramage G, Wickes B, López-Ribot J: Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 2007; 164: 301-306. (Pubitemid 47622130)
21. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II: Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006; 50: 1865-1868.
22. Ates M, Akdeniz B, Sen B: The effect of calcium chelating or binding agents on Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 626-630. (Pubitemid 41483649)
23. Chandra SS, Miglani R, Indira R: Antifungal efficacy of 5.25% sodium hypochlorite, 2% chlorhexidine gluconate, and 17% EDTA with and without an antifungal agent. J Endod 2010; 36: 675-678.
24. Shakoor S, Khan E, Zafar A, Hasan R: In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant acinetobacter species: report from a tertiary care centre in Karachi, Pakistan. Chemotherapy 2010; 56: 184-189.
25. Greer ND: Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc (Bayl Univ Med Cent) 2006; 19: 155-161.
26. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R: Comparative activities of daptomycin, linezolid and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007; 51: 1656-1660. (Pubitemid 46744141)
27. Bedeni? B, Vranes J, Sviben M, Beader N, Kaleni? S: Postantibiotic and post-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo-lactamases. Chemotherapy 2008; 54: 188-193. (Pubitemid 351929269)
28. Nagano R, Adachi Y, Imamura H, Yamada K, Hashizume T, Morishima H: Carbapenem derivatives as potential inhibitors of various-lactamases, including class B metallo-lactamases. Antimicrob Agents Chemother 1999; 43: 2497-2503. (Pubitemid 29471234)
29. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, Goto M: Convenient test for screening metallo-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38: 40-43. (Pubitemid 30043261)
30. Aoki N, Ishii Y, Tateda K, Saga T, Kimura S, Kikuchi Y, Kobayashi T, Tanabe Y, Tsukada H, Gejyo F, Yamaguchi K: Efficacy of calcium-EDTA as an inhibitor for metallo-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia. Antimicrob Agents Chemother 2010; 54: 4582-4588.
31. Hanlon GW, Denyer SP, Lambert RJ: The synergistic effect of EDTA and antimicrobial combinations on Pseudomonas aeruginosa . J Applied Microbiol 2004; 96: 244-253. (Pubitemid 38223550)
32. Hanna HA, Graviss L, Chaiban G, Dvorak T, Arbuckle RB, Estey E, Munsell M, Hachem RY, Champlin R: Interscience Conference on Antimicrobial Agents and Chemotherapy: susceptibility patterns of staphylococcal organisms in leukemia and bone marrow transplant (BMT) services after the use of minocycline/rifampin impregnated central venous catheters (MR-CVC) in a cancer hospital. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 2002; 42:K-74.
33. Darouiche RO, Raad II, Bodey GP, Musher DM: Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents 1995; 6: 31-36.
34. Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I: Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004; 22: 3163-3171. (Pubitemid 41103731)
35. Minuth JN, Holmes TM, Musher DM: Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and-resistant staphylococci. Antimicrob Agents and Chemother 1974; 6: 411-444.
36. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ: A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26: 520-524. (Pubitemid 40896141)
37. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W: In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 2003; 47: 3580-3585.
38. Donlan RM: Biofilms on central venous catheter: is eradication possible? Curr Top Microbiol Immunol 2008; 322: 133-161.
39. Levy SB: Antimicrobial resistance bacteria on the defence. Resistance stems from misguided efforts to try to sterilize our environment. BMJ 1998; 317: 612-613.
40. Landry D, Braden G, Gobeille S, Haessler S, Vaidya C, Sweet S: Emergence of gentamicinresistance bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010; 5: 1799-1804.
41. Roche B, Dacosta E, Guerraoui A: Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheter. Prospective study, 1999-2003. J Am Soc Nephrol 2004; 15: 368A (abstr).
42. Mermel L, Pelak M, Costerton J, Shah C: Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46: 1674-1679. (Pubitemid 34535182)
43. Deighton M, Rouch D, Daley A, Istivan T, Qu Y: Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negativ staphylococcal biofilms. J Med Microbiol 2009; 58: 442-450.
44. Weijmer MC, Van der Dorpel A, Van de Ven P: Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-2777.
45. Scherertz R, Boger M, Collins C, Mason L, Raad I: Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006; 50; 1865-1868.
46. Simon A, Ammann R, Wiszniewsky G, Bode U, Fleischhack G, Besuden M: Taurolidinecitrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infec Dis 2008; 8: 102-115.